Moderna (NASDAQ: MRNA)
Moderna Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Moderna Company Info
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA).
News & Analysis
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Is This a Setback for Moderna?
Moderna's shares slipped after the company announced the delay.
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Patience often pays off in the equity markets.
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
This team-up is more than a PR stunt, but it might not be revolutionary.
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
The COVID-19 pandemic thrust this company's science -- and its stock -- into the spotlight.
Moderna's Loss in Q1 Was Less Than Expected
Cost-cutting efforts and increased vaccine sales help Moderna surpass Q1 earnings and revenue projections.
Why Moderna Stock Blasted 13% Higher Today
The company notched beats on both the top and bottom lines despite a major drop-off in demand for its famous product.
Should You Buy Moderna Before May 12?
This ambitious biotech aims to launch 15 products over the coming five years.
Valuation
Podcast Episodes
Microsoft's Gaming Ambitions and COVID-19 Stocks
Microsoft CEO Satya Nadella talked about his company's doubling down on gaming, which should give gamers and investors pause.
What Gives Moderna's Coronavirus Vaccine an Edge?
Moderna has got some promising news on the coronavirus vaccine front.
Why Moderna Stock Is Up
Moderna shares got a boost as the company continued its COVID-19 vaccine trials.
Why Moderna Stock Just Went Up
Encouraging news coming out of the biotech regarding its coronavirus vaccine candidate caused its stock to pop.
Earnings Transcripts
Moderna (MRNA) Q1 2024 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2024.
Moderna (MRNA) Q4 2023 Earnings Call Transcript
MRNA earnings call for the period ending December 31, 2023.
Moderna (MRNA) Q3 2023 Earnings Call Transcript
MRNA earnings call for the period ending September 30, 2023.
Moderna (MRNA) Q2 2023 Earnings Call Transcript
MRNA earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.